Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Infliximab Infusion Time Protocol
NCT05340764Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2020
- Primary completion
- May 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in inflammatory bowel disease (IBD), sponsored by Washington University School of Medicine. Started Aug 2020; status: completed.
02
Drugs
infliximab
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT05340764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340764.